AMY HUDSON: Open Payments
NPI 1023580487 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 69 payments from 11 companies in 2025. Trend: 2023 $21 · 2024 $89 · 2025 $1,519
Food & beverage: $1,519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $432 |
| Axsome Therapeutics, Inc. | 12 | $406 |
| Vanda Pharmaceuticals Inc. | 7 | $218 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $217 |
| Otsuka America Pharmaceutical, Inc. | 5 | $78 |
| Corium, LLC | 4 | $46 |
| Alkermes, Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Tris Pharma Inc | 1 | $20 |
| Indivior Inc. | 1 | $15 |
Products named: VRAYLAR, Auvelity, CAPLYTA, FANAPT, REXULTI, Azstarys, SPRAVATO, LYBALVI.
Industry payments across KY — which companies pay providers there.
